The Intersectoral Global Action Plan (IGAP): A unique opportunity for neurology across the globe.

Brain health Intersectoral Global Action Plan (IGAP) Policy makers Prophylaxis Public health Research Therapy World Federation of Neurology (WFN) World Health Organization (WHO)

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 06 2023
Historique:
received: 01 04 2023
accepted: 03 04 2023
medline: 16 5 2023
pubmed: 17 4 2023
entrez: 16 4 2023
Statut: ppublish

Résumé

The World Health Assembly (WHA) approved the Intersectoral Global Action Plan (IGAP) in 2022. This ambitious project, formally called the Intersectoral Global Action Plan for Epilepsy and Other Neurological Disorders, is a 10-year plan to enhance neurology implementation worldwide and to raise the status of brain health and neurology services for patients with neurological diseases. The IGAP has 5 important components: relation with policy makers, therapy, prophylaxis, research, and public health. The implementation of IGAP is a challenge, not only for the specialty of neurology but for the whole neurological community, encompassing patients, carers, healthcare providers, and the public. The lack of a unified definition of neurology and the great variety of health systems, as well as the dependency on socioeconomic status, will necessitate custom-made solutions in all regions.

Identifiants

pubmed: 37062176
pii: S0022-510X(23)00105-3
doi: 10.1016/j.jns.2023.120645
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

120645

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests.

Auteurs

Wolfgang Grisold (W)

World Federation of Neurology, London, United Kingdom. Electronic address: info@wfneurology.org.

Morris Freedman (M)

World Federation of Neurology, London, United Kingdom.

Riadh Gouider (R)

World Federation of Neurology, London, United Kingdom.

Alla Guekht (A)

World Federation of Neurology, London, United Kingdom.

Steven Lewis (S)

World Federation of Neurology, London, United Kingdom.

Marco Medina (M)

World Federation of Neurology, London, United Kingdom.

Chandrashekhar Meshram (C)

World Federation of Neurology, London, United Kingdom.

Guy Rouleau (G)

World Federation of Neurology, London, United Kingdom.

Richard Stark (R)

World Federation of Neurology, London, United Kingdom.
World Federation of Neurology, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH